Wanbury has successfully completed US Food and Drug Administration (USFDA) inspection a at its API facility in Patalganga Plant, Maharashtra. The audit was carried out for a period of 4 days from September 26 to September 29, 2016 and concluded successfully. This is the second plant to be approved by USFDA this year, as earlier Tanuku Plant got approval two months ago in July 2016.
Wanbury, one of India’s fastest growing pharmaceutical companies amongst the ‘Top 50 Companies’ in India (as per ORG-IMS), has a strong presence in API global market and domestic branded Formulation. The company’s major thrust area lies in Active Pharmaceutical Ingredient (API) sale in over 70 countries and Pan-India Formulation presence.
Mr. K. Chandran, Wholetime Director & Vice Chairman
MR K. CHANDRAN (left), Director, Wanbury, and Mr Asok Shinkar
| Patalganga Plant | |||||
| US FDA approved plant is located at Kaire Village, Taluka: Khalapur, District: Raigad, Maharashtra State. It is situated in Maharashtra Industrial Development Corporation (MIDC), a Govt. notified industrial park for chemical manufacturing. The site is located 80 kilometers south of Mumbai International Airport and is easily accessible by road. | |||||
|
|||||
//////////Wanbury, USFDA inspection, API facility, Patalganga Plant
Sorry, the comment form is closed at this time.